Liu Zhaoxiang, Xiao Luqi, Jin Chenxi, Xiao Jianzhong, Zhao Wenhui
Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, People's Republic of China.
Diabetes Metab Syndr Obes. 2022 Aug 6;15:2377-2380. doi: 10.2147/DMSO.S373712. eCollection 2022.
Bariatric surgery is an effective therapy for type 2 diabetes mellitus (T2DM) and obesity. Euglycaemic ketoacidosis (EKA) has been reported in patients taking sodium-glucose cotransporter 2 (SGLT2) inhibitors after bariatric surgery. Cases of T2DM complicated with EKA without SGLT2 inhibitors after bariatric surgery are rarely reported.
To present a case report of a T2DM patient (without SGLT2 inhibitor use) who developed EKA soon after laparoscopic sleeve gastrectomy.
Clinical records and interviews were used.
A 35-year-old female patient was diagnosed with T2DM and obesity. The patient underwent laparoscopic sleeve gastrectomy to lose weight and control her blood glucose levels. Her daily fluid intake was 800-1000 mL, and her daily caloric intake was less than 500 kcal during the first days after the surgery. She was prescribed degludec insulin, metformin and dulaglutide and her blood sugar was lower than 13.9 mmol/L. On postoperative Day 6, the patient complained of fatigue and vomiting. Blood gas analysis and urine analysis supported the diagnosis of ketoacidosis. Fluid resuscitation, insulin and glucose were administered to the patient immediately. On postoperative Day 8, the patient recovered without any symptoms.
We report an extremely rare case of T2DM in which the patient developed EKA after laparoscopic sleeve gastrectomy owing to extremely low-calorie intake and dehydration. Physicians should be on alert for ketoacidosis in patients with T2DM after bariatric surgery with an euglycaemic status, even without the use of SGLT2 inhibitors or the presence of stresses, such as infection.Level V: Opinions of respected authorities, based on descriptive studies, narrative reviews, clinical experience, or reports of expert committees.
减重手术是治疗2型糖尿病(T2DM)和肥胖症的有效方法。有报道称,减重手术后服用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的患者会发生正常血糖性酮症酸中毒(EKA)。减重手术后,很少有T2DM合并EKA且未使用SGLT2抑制剂的病例报道。
报告1例T2DM患者(未使用SGLT2抑制剂)在腹腔镜袖状胃切除术后不久发生EKA的病例。
采用临床记录和访谈。
1例35岁女性患者被诊断为T2DM和肥胖症。该患者接受腹腔镜袖状胃切除术以减重并控制血糖水平。术后头几天,她的每日液体摄入量为800 - 1000 mL,每日热量摄入低于500千卡。她被处方了德谷胰岛素、二甲双胍和度拉鲁肽,血糖低于13.9 mmol/L。术后第6天,患者诉乏力和呕吐。血气分析和尿液分析支持酮症酸中毒的诊断。立即对患者进行了液体复苏、胰岛素和葡萄糖治疗。术后第8天,患者康复,无任何症状。
我们报告了1例极为罕见的T2DM病例,该患者因极低热量摄入和脱水在腹腔镜袖状胃切除术后发生EKA。医生应警惕减重手术后血糖正常的T2DM患者发生酮症酸中毒,即使未使用SGLT2抑制剂或不存在感染等应激因素。V级:基于描述性研究、叙述性综述、临床经验或专家委员会报告的权威意见。